Immunotherapy deserves cautious optimism – SBS
|
Immunotherapy deserves cautious optimism
SBS Immunotherapy is set to transform the landscape of how cancer is treated in the next five to 10 years however Australians have been cautioned it won't be the miracle cure for every patient. Immunotherapy drugs like pembrolizumab (Keytruda) and … |
